Cardiovascular Journal of Africa: Vol 23 No 6 (July 2012) - page 83

For full prescribing information, refer to package insert approved by medicines regulatory authority.
S3
CORALAN
®
5 mg Tablets. Ivabradine 5 mg. Reg. No. A39/7.1.4/0410
S3
CORALAN
®
7,5 mg Tablets. Ivabradine 7,5 mg. Reg. No. A39/7.1.4/4011
NAME AND BUSINESS ADDRESS OF THE HOLDER OF THE CERTIFICATE: SERVIER LABORATORIES SOUTH AFRICA
(Pty) Ltd. Reg. No. 72/14307/07. Building Number 4, Country Club Estate, 21 Woodlands Drive, Woodmead
2191. PO Box 930, Rivonia 2128, Republic of South Africa. TEL: +27(0) 861 700 900. FAX: +27(0)11 525 3401.
References: 1.
Vilaine JP et al. J Cardiovasc Pharmacol 2003;42:688-696.
2.
Camm A et al. Drugs R&D
2003;4:83-89.
3.
Borer J et al. Circulation 2003;107:817-823.
4.
Swedberg K et al. Lancet 2010;376:875-885.
S L O W
the beat
Improve the outcome
Coralan
®
specifically reduces
heart rate without affecting
cardiac contraction
1
, conduction
2
or blood pressure
3
Coralan
®
has powerful
anti-anginal and
anti-ischaemic efficacy
3
Coralan
®
improves outcomes in
heart failure patients with a heart
rate above 70bpm - SHIFT
4
1...,73,74,75,76,77,78,79,80,81,82 84
Powered by FlippingBook